title: Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.
authors.affiliation: Department of Neurology, Cantonal Hospital of Aarau, Aarau, Switzerland.
authors.forename: Lutz
authors.initials: L
authors.lastname: Achtnichts
authors.affiliation: Department of Neurology, Cantonal Hospital of Aarau, Aarau, Switzerland.
authors.forename: Otilia
authors.initials: O
authors.lastname: Obreja
authors.affiliation: Department of Infectious Diseases, Cantonal Hospital of Aarau, Aarau, Switzerland.
authors.forename: Anna
authors.initials: A
authors.lastname: Conen
authors.affiliation: Department of Infectious Diseases, Cantonal Hospital of Aarau, Aarau, Switzerland.
authors.forename: Christoph A
authors.initials: CA
authors.lastname: Fux
authors.affiliation: Department of Neurology, Cantonal Hospital of Aarau, Aarau, Switzerland.
authors.forename: Krassen
authors.initials: K
authors.lastname: Nedeltchev
mesh_terms: D000328:Adult; D001921:Brain / Q000473:pathology*; D003453:Cryptococcosis / Q000134:cerebrospinal fluid / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D003454:Cryptococcus; D000068876:Fingolimod Hydrochloride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008590:Meningoencephalitis / Q000134:cerebrospinal fluid / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D009103:Multiple Sclerosis / Q000150:complications*; D016896:Treatment Outcome
chemical_list: D000068876:Fingolimod Hydrochloride